Drugmakers Stockpiling for Brexit Ask, How Long Do We Wait?
- Costs climb as pharma companies maintain larger inventories
- Insulin maker Novo is keeping stockpiles at about 18 weeks
This article is for subscribers only.
Pharma companies ramped up their stockpiles of drugs to prepare for a potentially chaotic Brexit. Now they’re in the dark about how long they’ll need to hold them.
As uncertainty surrounding the U.K.’s withdrawal from the European Union drags on, the costs and frustration are mounting. Novo Nordisk A/S, the world’s largest insulin maker, is keeping inventories of the life-saving medicine at more than twice normal levels and topping them up as products move to the market.